News
AZ, Avillion's Airsupra aces asthma rescue therapy trial
A trial of AstraZeneca and Avillion's first-in-class asthma rescue …
19694 items found
News
Activist investor Starboard builds $1bn Pfizer stake
The week has started with reports that activist investor Starboard …
News
Mendaera's $73m raise heads digital financings
Recent financings in the digital health sector include a $73 million …
R&D
LSX 2024 - Luba Greenwood and Hakim Yadi
High-profile digital health investor Luba Greenwood recently …
News
Mounjaro and Zepbound shortages over, declares FDA
The US Food and Drug Administration (FDA) has declared an end to the …
News
FDA approval gives BMS an edge in NSCLC treatment
Bristol Myers Squibb (BMS) has secured another win for Opdivo …
R&D
Boehringer Ingelheim and Veeva: A data partnership for One Medicine
Boehringer’s Medicine Excellence initiative harnesses technology with …
R&D
Investment outlook: Key takeaways from LSX USA
Investment and strategic partnerships are the lifeblood of innovation …
Oncology
ESMO 2024 - Henar Hevia & Carolyn Sousa
ESMO 2024 was chock full of oncological data, diverse presentations …
News
Gilead strikes deal to expand HIV drug access in 120 countries
Gilead Sciences has taken a major step towards increasing global …
News
Research shows NHS, industry partnership benefits patients
A new report commissioned by the Association of the British …
Digital
Changing Faces – Digital and supplier hires for September 2024
September was a significant month for the companies that support the …
News
AbbVie gets continuous Parkinson's drug over the line in US
AbbVie has finally claimed FDA approval for its advanced Parkinson's disease therapy Vyalev, 18 months after the US regulator turned it down with a request for more data.
Digital
Sponsored
Decoding physician prescribing behaviour: A data-driven jour...
Identifying high-volume prescribers and engaging with key opinion leaders (KOLs) in a target therapeutic area can be a challenge.
Sales & Marketing
Deep Dive: Commercialisation 2024
In this issue, we unpack Ozempic’s rise to superstar status and the risks associated with its off-label use.
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
Digital
Access to genomic surveillance: Open science and public heal...
The pandemic served as a catalyst for a revolution in genomic surveillance for tracking pathogens.
Sales & Marketing
Sponsored
Launch Excellence: Moments of Truth
The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.
R&D
Partner Content
BIO-Europe's 30th Anniversary Landmark Event in Stockholm
BIO-Europe™ celebrates 30 years of facilitating partnerships this Fall. In 1994, BIO-Europe launched with the mission to drive biotech innovation and
R&D
Partner Content
8th Dermatology Drug Development Summit
Industry’s Destination to Discover & Develop Best-In-Class Drugs for Immuno-Inflammatory Skin Disease
